Cargando…
Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004
Pancreatic ductal adenocarcinoma (PDA) is the fourth-leading cause of cancer death in the United States with a 5-year overall survival rate of 8% for all stages combined. But this decreases to 3% for the majority of patients that present with stage IV PDA at time of diagnosis. The lack of distinct e...
Autores principales: | Wu, Shu-ta, Williams, Chandra D., Grover, Priyanka A., Moore, Laura J., Mukherjee, Pinku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819830/ https://www.ncbi.nlm.nih.gov/pubmed/29462213 http://dx.doi.org/10.1371/journal.pone.0193260 |
Ejemplares similares
-
Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
por: Dréau, Didier, et al.
Publicado: (2019) -
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2019) -
Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors()()
por: Moore, Laura Jeffords, et al.
Publicado: (2016) -
Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer
por: Nath, Sritama, et al.
Publicado: (2015) -
A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis
por: Zhou, Ru, et al.
Publicado: (2016)